CAS 1959537-86-0

Formule : C27H28N6O5S

InChI : InChI=1S/C27H28N6O5S/c1-3-39(37,38)30-23-7-5-4-6-21(23)19-8-10-20(11-9-19)25(34)32-14-12-27(36,13-15-32)17-33-18-28-24-22(26(33)35)16-29-31(24)2/h3-11,16,18,30,36H,1,12-15,17H2,2H3

Code InChI : GFNJQQBUZURQMA-UHFFFAOYSA-N

SMILES : CN1C2=C(C=N1)C(=O)N(C=N2)CC3(CCN(CC3)C(=O)C4=CC=C(C=C4)C5=CC=CC=C5NS(=O)(=O)C=C)O

FT827

CAS : 1959537-86-0

FT827

Formule : C₂₇H₂₈N₆O₅S

Degré de pureté : ≥98%

Masse moléculaire : 548.61

Ref: 54-BUP02255

FT827

CAS : 1959537-86-0

Formule : C₂₇H₂₈N₆O₅S

Masse moléculaire : 548.6134

Ref: IN-DA01FNFF

FT827

CAS : 1959537-86-0

FT827 is a small molecule that is a covalent inhibitor of ubiquitin ligases. FT827 inhibits the activity of the proteasome by inhibiting ubiquitin ligases and proteasome-dependent protein degradation. FT827 has been shown to inhibit cancer growth in organoids, as well as infection by Borrelia burgdorferi, an agent of Lyme disease. FT827 was also shown to inhibit the replication of rabies virus in vitro. The precise molecular mechanism of action for this drug remains unknown, but it may be due to its ability to inhibit ubiquitin ligases. !--END-->

Formule : C₂₇H₂₈N₆O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 548.6 g/mol

Ref: 3D-JDD53786

FT827

CAS : 1959537-86-0

FT827 is a covalent inhibitor of USP7 that targets the catalytic center of the autoinhibitory apolipoprotein form of USP7 for cancer research.

Formule : C₂₇H₂₈N₆O₅S

Degré de pureté : 98.63%

Couleur et forme : White Solid

Masse moléculaire : 548.613

Ref: TM-T15351